Heat Biologics, Inc. HTBX

Set alert

Price alert · HTBX

All alert types
2.38 +2.38 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
61.07M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-1.62
Beta
0.30
Short ratio
0.00
Inst. own
10.76%
Dividend
0.00
Ex-div date
Earnings
May 4, 2022
50-d avg
2.57
200-d avg
4.11
1y target
11.38

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for HTBX has not been loaded yet. Try again in a moment.

Analyst view

Consensus: buy

Buy
Price target (mean) 11.38 +378.2% upside
Target (low)
8.00
Target (mean)
11.38
Target (high)
15.50
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 4
  • 2 months ago 4
  • 3 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

HTBX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.49-0.53 – -0.46-0.31-58.1%212.00K-60.7%2
Next quarter-0.47-0.53 – -0.42-0.26-80.8%1.40M0.0%2
Current year-1.71-2.10 – -1.30-1.41-21.3%4.43M+109.7%3
Next year-1.47-1.75 – -1.32-1.71+14.0%4.67M+5.4%3

Upgrades and downgrades

The latest rating changes

HTBX analyst upgrades and downgrades
DateFirmActionFromTo
Mar 3, 2021Cantor FitzgeraldInitiated—Overweight
Oct 14, 2020B. Riley FBRInitiated—Buy
Feb 6, 2020Maxim GroupInitiated—Buy
Jul 30, 2019Brookline CapitalInitiated—Buy
Jun 26, 2018H.C. WainwrightInitiated—Buy
Jun 20, 2016Roth CapitalInitiated—Buy
Feb 4, 2016Cantor FitzgeraldDowngradeBuySpeculative Buy
May 26, 2015H.C. WainwrightInitiated—Buy
Sep 23, 2013Aegis CapitalInitiated—Buy
Sep 18, 2013Aegis CapitalInitiated—Buy
Sep 3, 2013Canaccord GenuityInitiated—Buy